Structures by: Wittine K.
Total: 9
(Z)-1-(4'-benzamide-2'-butenyl)cytosine
C15H16N4O2
Crystal Growth & Design (2012) 12, 11 5262
a=8.7354(6)Å b=9.8973(6)Å c=32.784(3)Å
α=90° β=90° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)-5-fluorocytosine
C15H15FN4O2
Crystal Growth & Design (2012) 12, 11 5262
a=8.5569(6)Å b=10.0070(6)Å c=33.317(4)Å
α=90° β=90° γ=90°
(Z)-1-(4'-(4''-fluoro)benzamide-2'-butenyl)cytosine
C15H15FN4O2
Crystal Growth & Design (2012) 12, 11 5262
a=16.4507(9)Å b=8.7236(3)Å c=9.9629(4)Å
α=90° β=90.171(5)° γ=90°
(Z)-1-[4'-(4''-fluoro)benzamide-2'-butenyl]-5-fluorocytosine hemihydrate
2(C15H14F2N4O2),H2O
Crystal Growth & Design (2012) 12, 11 5262
a=14.4861(5)Å b=19.8854(7)Å c=21.2864(8)Å
α=90° β=90° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)uracil
C15H15N3O3
Crystal Growth & Design (2012) 12, 11 5262
a=16.2425(8)Å b=11.2706(5)Å c=15.9376(9)Å
α=90° β=100.630(5)° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)-5-fluorouracil
C15H14FN3O3
Crystal Growth & Design (2012) 12, 11 5262
a=16.9098(7)Å b=11.2132(4)Å c=15.4936(7)Å
α=90° β=100.660(5)° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)thymine
C16H17N3O3
Crystal Growth & Design (2012) 12, 11 5262
a=11.7837(13)Å b=10.9280(8)Å c=23.738(2)Å
α=90° β=100.754(10)° γ=90°
(Z)-1-[4'-(4''-fluoro)benzamide-2'-butenyl]thymine
C16H16FN3O3
Crystal Growth & Design (2012) 12, 11 5262
a=5.921(2)Å b=30.199(10)Å c=10.162(4)Å
α=90° β=119.67(2)° γ=90°
(Z)-4-chloro-2-butenylbenzamide
C11H12ClNO
Crystal Growth & Design (2012) 12, 11 5262
a=4.3098(4)Å b=25.4209(16)Å c=9.7322(5)Å
α=90° β=96.947(7)° γ=90°